Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Beautiful buying.
People want shares!
Yes now $.274
25K bid at $.25.
And the bids keep moving up nicely.
Nice buys at $.28.
Almost gone.
After someone takes out those $.28s we could sail back into the $.30s.
We have traded over 600k so far today. We know we have some flippers but I believe a lot of those 600k are now in strong hands. Flippers who picked up shares in the teens are getting cleared out and those who got shares in the .20s and are flipping will be cleaned out soon too.
Very good day so far.
Yes I agree..flipper.
It won't matter when SOLI starts to report much higher revenue.
The MAXIS GBN deal with CareClix was signed on 12/3/19. I am sure some lead time was needed to start to see the revenue start. So I don't expect much impact in Dec. 2019.
But for the first Q of 2020 and given the Coronavirus we should really start to see a revenue impact.
If you haven't seen the reach of MAXIS world wide please click on this link for their map. It is so impressive.
https://maxis-gbn.com/maxis-network/network-map/
Rstar, thanks for all the buying. You started it!!
As you and I have discussed before, the growth in revenue will enable the PPS and buying to be sustained.
Very nice buying now
Good job buddy...keep smacking.
The share structure was updated today.
No change to AS, OS or Restricted since 2 weeks ago.
You can simply look on OTC Market!!!
SOLI is "Transfer Agent Verfied". LOL
Do you know what that means?
Nothing is wrong. Only people who don't understand.
DTGoody, it is like you read my mind ( and some of my posts).
I agree with your points;
-growing revenue is job #1
-I believe that management has their plan are working it, even if some think that they should be doing other stuff.
-when revenue grows the way we think it can given the recently signed deals, wallstreet with notice and the PPS will take care of itself. So I give a reverse less than a 33% chance. And if one is announced, it would be a small one. Management owns most of the stock and is not going to hurt themselves.
There have been a number of posts regarding CareClix revenue and customers. Shareholders lack clarity in how much revenue is produced per contact and by what customer.
Below is a portion of the last Q regarding revenue. It clearly states that; "The identity of the client, the related performance obligations, the various transaction prices for different levels and frequency of use are all determined by the individual service agreements with each client"
Although it is frustrating not being able to analyze CareClix revenue, not making public the details of each contract gives CareClix the flexibility in negotiating deals to maximum benefit ( competitive advantage for CareClix).
SaaS: The CareClix software system is used by certain third-party customers to service their telemedicine clients under written service agreements with CareClix, Inc. Those clients generally pay a co-pay at the time of service, in most cases by credit card, and those co-pay fees are transmitted to CareClix, Inc. through STRIPE, a card processing service, as part of the third-party service agreement. That revenue is recognized as received. On a monthly basis, the balance of the client fees is billed, and the invoice is charged to service revenue immediately. The identity of the client, the related performance obligations, the various transaction prices for different levels and frequency of use are all determined by the individual service agreements with each client, and the CareClix software maintains all of the details of the price, performance, frequency and billing under each contract. The co-pay fees are received after the completion of the service provided to the telemedicine client by the CareClix customer and the balance due for those services is billed monthly in arrears by CareClix. Total revenues from SaaS for the three and nine months ended September 30,2019 was $216,470 and $394,797, respectively.
Telemedicine Revenues: Other customers of CareClix use the CareClix telemedicine platform directly to service their clients or members and the CareClix software maintains the record of the number of consultations and other work performed for the customer’s clients, using the CareClix contracted medical doctors, and CareClix bills the customer monthly for all services provided during the month, in accordance with the written agreement between CareClix and the customer. That revenue is recognized as income at the time it is invoiced since it is for services already rendered during the month of billing. Total telemedicine for the three and nine months ended September 30,2019 was $311,506 and $568,122, respectively.
Approximately 58 percent of the Company revenues for the nine months ended September 30, 2019 were derived from three customers, in the amounts of 34, 12 and 12 percent.
BAHAHAHA! Good one.
The run last year was based on speculation and wasn't sustained. The run that will happen this year will be based on revenue growth and will be sustained.
I know what I own here.
I did my DD and post facts on this board. I don't avoid backing up my statements.
Yeah right!! Everyone believes that. LOL
You are correct about MAXIS, Trapollo and Chile...all CareClix.
What we know is that when SOLI acquired CareClix they acquired the operating software, pending patent for that software, the domain name and trademark for the software and certain related incidental tangible assets. ( all of this is in the Q's).
They did NOT acquire any other assets, "although certain customers of KB Medical continued working with the Company after the acquisition because they were already using the CareClix operating software acquired by the Company".
What we don't know from the last two Q's is what revenue came from what customers and their customer base ( I suspect that they are not letting the public know curtain info. for competitive reasons).
We do know is that CareClix basically started from a base of zero revenue two Q's ago and reported $532K last Q before signing the big deals listed above.
"In early 2019, the Company entered into an agreement to acquire the proprietary CareClix™ operating software, and pending patent for that software, the domain name and trademark for the software and certain related incidental tangible assets of KB Medical Systems, LLC, an unrelated Company and the developer of the proprietary CareClix™ operating systems for telemedicine providers. The acquisition was closed April 12, 2019. Under the terms of the acquisition agreement, the Company formed a new, wholly-owned subsidiary CareClix, Inc., to acquire the CareClix™ operating software and pending patent and commenced a new operating business with the assets following the acquisition. The Company did not acquire cash, accounts receivables, or any other assets, any liabilities of KB Medical, and no customer lists, although certain customers of KB Medical continued working with the Company after the acquisition because they were already using the CareClix™ operating software acquired by the Company"
What "suspicious activity" has there been?
Any facts to backup that statement?
I'm betting on we make it BIG time! LOL
I know what I own and what is coming.
From the last PR on Chile:
About CareClix, Inc.
CareClix is a leading telemedicine solutions firm that provides software applications and a multispecialty medical network to a wide variety of health care services stakeholders. CareClix's suite of services is revolutionizing the way hospitals, doctors, and clinical care providers can interact with an increasing number of patients. CareClix Inc. is a wholly-owned subsidiary of Solei Systems Inc. (OTCPINK:SOLI). Learn more about CareClix by visiting our website: www.careclix.com.
From the PR on Trapollo:
About CareClix.
CareClix is a leading telemedicine solutions firm that provides software applications and a multispecialty medical network to a wide variety of health care services stakeholders. CareClix's suite of services is revolutionizing the way hospitals, doctors, and clinical care providers can interact with an increasing number of patients. CareClix Inc. is a wholly owned subsidiary of Solei Systems Inc. (OTC: SOLI). Learn more about CareClix by visiting our website: www.careclix.com.
Once the revenue grows dramatically the next 3-6 months SOLI will get it's day in the sun.
You don't cut a deal like MAXIS by "advertising". LOL
Like I said before, you are not selling a bottle of hand sanitizer or face masks.
Multi million dollar deals which effect operations, procedures, processes, patient behavior do take a little time.
I believe that the current corona problem will definitely help business/sales but it does take a little time.
Enough said.
We all know that moving a % of office visits to telemedicine is the future.
But it takes time to change operations, procedures, processes, etc., as well as $.
It also takes time to change patients behaviors. So if revenue is based on # of calls it takes time to ramp up.
So it not as easy as selling a bottle of hand sanitizer or a mask.
Maybe you should contact CareClix to do some selling?
Great post. What value!
Looking at the expenses from Q2 to Q3 of 2019:
-office salaries: same
-rent: same
-payroll: same
-consulting: up $20k
-professional fees: up $25K
-general and admin. expense: up $255k
I would expect that SOLI has hired sales people to increase revenue. How they are compensated is the question. We know from the last Q that some are
being paid with shares ( we have seen the OS & restricted go up).
Also we don't know all of the details of the MAXIS, Trapollo and Chile deals. I would think that leasing the platform for white label deals would have a higher margin and lower expense ( but lower revenue per unit) than full telemedicine service.
It is going to be very interesting to see what details we get in the 10K in a few weeks.
Agreed.
The MAXIS deal was PR'd on 12/3/19 so we should see very little impact in the 10K but bigger impact in Q1.
The Trapollo deal was PR's on 2/5/20 so maybe a little impact on Q1.
SOLI's management is totally focused on growing the revenue because they know that will lead to the success of the company and growth of the PPS.
The run last year was based on speculation and wasn't sustained. The run that will happen this year will be based on revenue growth and will be sustained.
Agree 100%.
Have a good evening too.
Great post! Nice to see actual people with actual experience posting facts to correct the guessing and assumptions being posted.
Excellent Post!!
You are right...facts don't lie. And people who make decisions based on DD(facts) usually make good decisions because it helps with the emotions.
Look on the CareClix website. They are currently hiring 9 Physicians.
You really need to do some DD.
You really need to read the filings!
The facts don't lie ( unlike some bartenders). CareClix is a top tier telemedicine company.
Can't wait until the minimum is down to 100 shares. LOL!
There are probably partial orders remaining in between the bid and ask that are less than the 5k limit to be listed.
It's like the old GEICO commerical: "it's so easy even a caveman can do it".
Understanding how SOLI is structured is easy if you want to.